M02AC - Preparations with Salicylic Acid Derivatives |
Not porphyrinogenic |
NP |
Rationale
Insignificant hepatic exposure. Inducer of CYP2C19. Several references consider it safe. Did not induce ALAS1 in rat.
Chemical description
ASA ointment for use in muscular pain.
Similar drugs
References
| # | Citation details | PubMed ID |
|---|---|---|
| 1. | Management of acute attacks in the porphyrias.
Kalman DR, Bonkovsky HL. Clin Dermatol. 1998; 16(2):299-306.
|
9554242 |
| Porphyria Drug Lists | ||
| 2. | French List
Centre Français des Porphyries
|
|
Tradenames